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Background: Sickle cell anemia patients suffer from oxidative stress due to chronic inflammation and self-oxidation
of sickle hemoglobin (Hb S). Chronic oxidative stress contributes to endothelial dysfunction, inflammation and
multiple organ damage in sickle cell disease (SCD). Thus, antioxidant medication may favorably influence the
disease. Gum Arabic (GA), edible, dried, gummy exudates from Acacia Senegal tree, has been claimed to act as an
anti-oxidant and cytoprotective agent, protecting against experimental hepatic, renal and cardiac toxicities in rats.
We hypothesized that regular intake of GA increases anti-oxidant capacity and reduce oxidative stress.
Methods: Forty-seven patients (5–42 years) carrying hemoglobin SS were recruited. Patients received 30 g/day GA for
12 weeks. Total anti-oxidant capacity (TAC), malondialdehyde (MDA) and hydrogen peroxide (H2O2) levels were measured
by spectrophotometric methods before and after GA intake. Complete blood count was measured by sysmex.
Results: Gum Arabic significantly increased TAC level P < 0.001and decreased the oxidative markers MDA (P < 0.05) and
H2O2 (P < 0.005).
Conclusions: GA has potent anti- oxidative properties in sickle cell anemia. The anti-oxidant effect of GA may thus
favorably influence the clinical condition of this and further diseases characterized by oxidative stress.
Trial registration: ClinicalTrials.gov Identifier: NCT02467257. Registered 3rd June 2015. Retrospective registration.
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Chronic inflammation with oxidative stress emerged as
an important pathogenic mechanism in sickle cell
disease (SCD) [1–3]. SCD is primarily a disorder of
RBCs, which are a significant source of free radicals in
biological systems [4]. Oxidative stress may thus contrib-
ute to the abnormalities that underlie the clinical course
of SCD [4]. Oxidative stress is one of the factors that
modulate the phenotypic expression of SCD [5]. Oxygen
has the ability to form highly reactive metabolites such
as superoxide anion radical (O2 −2), hydrogen peroxide
(H2O2), and hydroxyl radical (•OH). These reduced me-
tabolites of oxygen are referred to as “reactive oxygen
species ROS” [6]. Oxidative stress can damage specific
molecular targets (lipids, proteins, carbohydrates etc.),* Correspondence: lamiskaddam@hotmail.com
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stress level increases during vaso-occlusive crises and
acute chest pain [7]. Oxidative stress is not only linked
to chronic inflammation, it also contributes to endothe-
lial dysfunction [8].
Sickle cell anemia patients have high levels of oxidative
stress markers and low levels of antioxidant capacity. In
addition to oxidative stress SCD patients have lower
plasma levels of the antioxidant vitamins (A, C and E),
lower serum levels of zinc and significantly higher serum
levels of copper in comparison to controls [9, 10]. Zinc
deficiency with a copper excess may contribute to free
radical production and oxidative damage [9]. Deficiency
of antioxidant vitamins (A, C and E) could account for
some of the observed manifestations of SCD such as
increased susceptibility to infection and hemolysis [11].
Any medication that increases the antioxidant capacity
is thus expected to favorably influence the clinical course
of the disease. Gum Arabic (GA) is an edible, dried,le is distributed under the terms of the Creative Commons Attribution 4.0
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Senegal and Acacia Seyal. Oral intake of GA has been
shown to provide several health benefits [12], such as
prebiotic effects [13]. GA significantly increases Bifido-
bacteria, Lactobacteria, and Bacteriodes in the gut [13].
GA is claimed to have anti-cancer [13], anti-malarial
[14] and immune-modulatory effects [14, 15]. GA is
considered to act as an anti-oxidant and cytoprotective
agent [16] and it can protect against experimental hep-
atic, renal and cardiac toxicities in rats [19]. GA is as-
sumed to be effective mainly due to strong anti-oxidant
properties [17, 20, 21]; GA may enhance the activity of
superoxide dismutase (SOD) in kidney [22]. Amino acids
tyrosine, histidine and methionine seem to be respon-
sible for the antioxidant capacity of GA against ROS
[23]. In experimental chronic renal failure (CRF) in rats
GA administration decreased the superoxide production
to control levels and raised the level of GSH and TAC.
Alyahia et al. revealed that GA offers protection against
cyclophosphamide-induced urinary bladder cytotoxicity
in a rat model by neutralizing ROS and mitigating oxida-
tive stress [16]. GA was effective as a potent superoxide
scavenger in doxorubicin induced cardiotoxicity murine
model [24]. Moreover, GA was found to decrease MDA
renal level on Cisplatin-Induced nephrotoxicity rat
model [25].
These observations suggest that GA may find clinical
application in a variety of conditions where cellular dam-
age is a consequence of oxidative stress like sickle cell
anemia. We hypothesized that regular intake of GA would
increase the TAC and decrease the oxidative stress
markers. The present study tested whether Gum Arabic
may have anti-oxidant properties in SCA patients.
To the best of our knowledge this is the first study
conducted to investigate the effect of oral administration
of GA on anti-oxidant capacity in sickle cell anemia
patients.
Methods
The participants of this study were recruited from the
out patients clinic of pediatric and adult hematology
units in Military Hospital-Khartoum-Sudan. The Inclu-
sion criteria were: patients homozygous for SCD (SS) as
documented by Hemoglobin electrophoreses. Their age
ranged between 5 and 50 years. The total number of
participants recruited was 47. All medications and dos-
ages had been stable for 2 weeks before study entry. Ex-
clusion criteria: patients receiving blood transfusion
within the last three months or admitted to the hospital
within 2 weeks because of SCD-related events or crisis.
Gum Arabic administration
GA in powder form is a 100% natural extract powder
produced mechanically from the wildly grown AcaciaSenegal tree with a particle size less than 210 μm. GA in
powder form was provided from Dar Savanna Ltd.,
Khartoum, Sudan. Properties and composition of GA are
listed elsewhere [26]. The daily dose was 30 g, given in
one sachet to be consumed early morning dissolved in
water for 12 weeks. The GA was provided to the partici-
pants every two weeks for three months (14 sachets per
each visit). Empty sachets were retained every visit as
indicator of compliance.
Sample collection and colorimetric determination of TAC
and oxidative markers
Blood sample was collected before administering GA
and after 12 weeks as follows:
Two ml in EDTA container and two ml in plain con-
tainer. The serum and plasma was separated by centrifu-
gation at 3000 rpm for 15 min then aliquot into four
eppendorf tubes and stored at −85 °C till final analysis.
All blood samples were collected by certified nurses in
Military Hospital.
Antioxidant capacity in the serum was determined by
the reaction of antioxidants in the sample with a defined
amount of exogenously added hydrogen peroxide (H2O2).
The antioxidants in the sample eliminated a certain
amount of the provided hydrogen peroxide. The residual
H2O2was determined calorimetrically by an enzymatic
reaction which included the conversion of 3,5,dichloro
−2– hydroxybenzene sulfonate to a colored product
[27].0.5 ml of H2O2 was added to 20 μl of serum and incu-
bated for 5 min at 37 °C. Working reagent was added and
immediately the absorbance of blank and sample were
read against distilled water at 505 nm.
The malondialdehyde level was calculated by the thio-
barbituric acid reactive species (TBARS) technique. This
method is based on the reaction of malondialdehyde and
other aldehydes, which are by products of membrane
damage caused by ROS, with thiobarbituric acid (TBA)
at low pH and high temperature forming a complex with
maximum light absorption at 535 nm [28]. One ml of
TBA was added to 200μl of serum, mixed well in the test
tube and boiled in 95 °C boiling water bath for 30 min.
The absorbance of sample against blank and standard
against distilled water was read at 534 nm.
Hydrogen peroxide was determined in the plasma by
the reaction of H2O2 with 3, 5-dichloro-2-hydroxyben-
zensulfonic (DHBS) acid and 4-aminophenazone (AAP)
in the presence of peroxidase (HRP) to form a chromo-
phore. This method had been developed by Fossati et al.
[29]. 500 μl of DHBS and 500 μl of AAP was added to
50 μl of plasma in a glass tube, and incubated for
10 min at 37 °C. The sample and standard were read
against blank at 510 nm.
Complete blood count was measured using automated
analyzer (Sysmex).
Table 1 Demographics and baseline characteristics
Characteristics Mean SD Median Maximum Minimum
Age 16.26 8.52 15 42 5
Gender 23(49%) Male
Base line weight (Kg) 35 · 96 14 37 · 3 63 13
Base line height (Cm) 148 · 34 20.99 154 · 5 107 190
Hb g/dL 7.28 1.105 7 11 5 · 5
Hb F (%) 6.68 5.44 4.80 17.50 00
Hb S (%) 89 · 99 5 · 15 91 97 · 20 79 · 40
HbA2 (%) 3 · 33 0 · 52 3 · 3 4 · 4 2 · 5
TAC mmol/L 0.32 0.077 0.33 0.50 0.17
MDA nmol/mL 6.35 3.73 6.0 14.4 0.29
H2O2mmol/L 0.47 0.21 0.46 1.44 0.15
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ples T test was used to compare between pre and post
intervention results. Person correlation was used to find
correlation between different parameters. P values equal
or less than 0.05 was considered significant.
Results
Forty seven patients were enrolled (Table 1). All were
Sudanese; 23 were males, age 5 to 42 years. Duration of
treatment was for 12 weeks except two patients received
GA for nine weeks and eight patients for ten weeks. The
last recorded results were considered for final analysis as
post treatment results.
Oral Gum Arabic intake significantly increased the
level of TAC (Fig. 1) and reduced the levels of both:
MDA (Fig. 2) and H2O2 (Fig. 3). Response rate was 60%.
We observed significant positive correlation between
base line TAC and hemoglobin (Fig. 4). We also found
significant correlation between MDA level and TWBC
count (Fig. 5). H2O2 level was positively correlated with
MCV baseline level (Fig. 6).Fig. 1 Effect of GA intake on TAC Level (P < 0.001)Discussion
Sickle cell anemia patients suffer from oxidative stress
[7] which is caused by chronic inflammation [1] and
self-oxidation of Hb S [30]. Chronic oxidative stress
contributes to endothelial dysfunction, inflammation and
multiple organ damage in SCD [30]. Antioxidant en-
zymes were significantly less in red blood cells of SCA
patients than in red blood cells of healthy controls [7].
Sickle erythrocytes have been shown to have elevated
levels of ROS as compared to normal (AA) erythrocytes
[1]. Chronic oxidative stress in SCD is caused by an
imbalance between the production of reactive oxygen
species (ROS) and antioxidant enzyme activity [8]
Agents that increase the antioxidant capacity of sickle
patients were expected to improve their clinical condi-
tion [7]. Trials of antioxidant agents in mouse models of
SCD also appear to reduce markers of acute and chronic
inflammation [1].
In our study GA increased TAC of patients (P < .0.001).
GA is known to have antioxidant properties, which have
been illustrated in animal model of CRF [18, 31]. GAFig. 2 Effect of GA intake on MDA Level (P < 0.05)
Fig. 3 Effect of GA intake on H2O2 Level (P < 0.005
Fig. 5 Linear regression between MDA and WBCs count (r2 = 0.102,
P < 0.05). Dependent Variable: Base line MDA level. Predictors:
(Constant), Base line WBCs level
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(SOD), catalase and glutathione [31]. GA microcapsules
found to be potent anti-oxidant agent in vitro [23]. Our
results confirmed that GA has anti-oxidative properties
which can be utilized to improve patient’s condition and
attenuate disease severity.
Oxidative stress, which is manifested by a significant
increase in the levels of MDA and inhibition of the per-
oxidase and catalase enzymes, presents a major cause of
the tissue damage [16]. MDA, which is a byproduct of
lipid peroxidation [7], is higher in SCA patients than
healthy controls [7].
GA significantly decreased MDA levels in a chronic
renal failure (CRF) animal model and nephrotoxicity
[25, 31]. In our study GA significantly decreased the
MDA level (Fig. 2). This interesting result indicates thatFig. 4 Linear regression between TAC and Hb level (r2 = 0.109,
P < 0.05). Dependent Variable: Base line hemoglobin level. Predictors:
(Constant), Base line TAC levelGA may have protective effect against oxidative stress and
tissue damage in these patients.
Hydrogen peroxide (H2O2) was viewed as a toxic mol-
ecule to human tissues [32]. Sickle cell erythrocytes
produce twice as much superoxide, H2O2 and hydroxyl
radical as compared to normal healthy controls [10]. GA
significantly decreased H2O2level in SCA patients (Fig. 3).
Several studies pointed to catalase as the primary enzyme
responsible for protecting the red cell from H2O2 [33].
GA increased catalase activity as evidenced in several
animal models [31, 34]. GA also increases H2O2 scav-
enging capacity in vitro [23]. This may explain the
decrease we have noticed in H2O2 level after taking
GA for 12 weeks.Fig. 6 Linear regression between H2O2 and MCV level (r
2 = 0.219,
P = 0.001). Dependent Variable: Base line H2O2 level. Predictors:
(Constant), Base line MCV level
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Our results provided more evidence that GA has potent
anti- oxidative effects in humans as demonstrated by its
ability to increase TAC and to decrease oxidative stress
markers in humans. All previous studies were conducted
in animal models or in vitro studies. The present study
thus uncovers a novel effect of GA which can be utilized
in other clinical conditions and diseases caused by in-
creased lipid peroxidation and tissue injury. Thus the in-
creased intake of dietary antioxidants from GA may help
to maintain an adequate antioxidant defense status and
consequently contribute to the management of SCD.
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